← Back to Search

Chemotherapy

Breast Mass Characterization for Breast Cancer

N/A
Recruiting
Led By Gregory J Czarnota, PhD, MD
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 to 8 months
Awards & highlights

Summary

Our objective in this pilot study will be to identify PA parameters that can distinguish benign vs. malignant lesions, and also, if PA parameters change with within breast tumors during chemotherapy treatment over time.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 to 8 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 to 8 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Treatment response correlation between photoacoustic parameters and histopathological measurement.
Secondary outcome measures
Breast mass characterization

Trial Design

2Treatment groups
Experimental Treatment
Group I: Neoadjuvant Chemotherapy MonitoringExperimental Treatment1 Intervention
The first arm Neoadjuvant Chemotherapy Monitoring will investigate changes of measured photoacoustic markers and compare to these to histopathological indicators of breast tumor response to NAC. Changes in photoacoustic parameters will be made to a pre-treatment point over the course of treatment. Treatment will not be modified on the basis of our observations. in this pilot observational study
Group II: Breast Mass CharacterizationExperimental Treatment1 Intervention
The second arm Breast Mass Characterization will investigate if breast masses (benign vs. malignant) can be characterized during clinical diagnostic work-up. Differences in the photoacoustic tissue-properties will be compared to histopathological evaluation.

Find a Location

Who is running the clinical trial?

Sunnybrook Health Sciences CentreLead Sponsor
671 Previous Clinical Trials
1,564,535 Total Patients Enrolled
29 Trials studying Breast Cancer
16,952 Patients Enrolled for Breast Cancer
Gregory J Czarnota, PhD, MDPrincipal InvestigatorSunnybrook Health Sciences Centre
6 Previous Clinical Trials
1,910 Total Patients Enrolled
4 Trials studying Breast Cancer
1,840 Patients Enrolled for Breast Cancer
~4 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top